Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

EARLY Antibiotics aDAptation in Severe Pneumonia(The EARLY ADAPT Study)

NCT: NCT07267624 · NOT_YET_RECRUITING

NCT IDNCT07267624
StatusNOT_YET_RECRUITING
Start Date2026-06-05
Completion2028-06-30

Brief Summary

The objective of the study is to determine whether rapid multiplex PCR testing of respiratory samples can reduce exposure to broad-spectrum antibiotics in intensive care unit patients with suspected or confirmed ventilator-associated pneumonia, compared to standard diagnostic methods. As secondary objectives, the investigators will study antibiotic management and overall antibiotic consumption, as well as escalation or de-escalation events. The investigators will study the potential clinical impact of using multiplex PCR to see if the length of stay in the intensive care unit is reduced, as well as the duration of mechanical ventilation.

Frequently Asked Questions

What is EARLY Antibiotics aDAptation in Severe Pneumonia(The EARLY ADAPT Study)?

EARLY Antibiotics aDAptation in Severe Pneumonia(The EARLY ADAPT Study) is a clinical trial registered under NCT07267624. Current status: NOT_YET_RECRUITING.

What is the status of NCT07267624?

The current status of NCT07267624 (EARLY Antibiotics aDAptation in Severe Pneumonia(The EARLY ADAPT Study)) is: NOT_YET_RECRUITING.

When did EARLY Antibiotics aDAptation in Severe Pneumonia(The EARLY ADAPT Study) start?

EARLY Antibiotics aDAptation in Severe Pneumonia(The EARLY ADAPT Study) started on 2026-06-05.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.